Founded in 1997, MVM Partners LLP invests broadly across the healthcare and life sciences sectors, including medical technology, pharmaceuticals, diagnostics, digital health, health IT, life science tools, contract research, and contract manufacturing. The firm provides growth equity to commercial-stage businesses with innovative products addressing significant unmet needs in large markets. MVM maintains offices in Boston, London, and the San Francisco Bay Area, managing investment vehicles totaling over $1 billion.
Is MVM Partners LLP the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with MVM Partners LLP, along with a list of other relevant VCs, is available on Hopohopo.io.
Stages
Series B or later
First ticket size
US$20,000,000 - US$100,000,000
When approaching MVM Partners, founders should highlight strong commercial traction and a clear path to scaling within large, addressable healthcare markets. Emphasize differentiated products or services that solve critical pain points and demonstrate robust clinical or market validation. MVM values teams with deep sector expertise and a proven ability to execute in regulated environments, so showcasing operational excellence and a track record of navigating complex healthcare landscapes will resonate.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.